Pharmaceutical composition for the prevention of recurrent urinary tract infection

摘要

The present disclosure relates to the use of PPS in the manufacture of a medicament for the prevention of recurrent urinary tract infection (rUTI) in a human subject comprising a therapeutically effective dosage for oral administration of sodium pentosan polysulfate (PPS), comprising: A therapeutically effective dosage for oral administration of PPS provides for use in the range of 5 to 1 mg/kg/day.